{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T20:21:08Z","timestamp":1760473268125,"version":"3.41.2"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"publisher","award":["23K19653"],"award-info":[{"award-number":["23K19653"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["21KK0157"],"award-info":[{"award-number":["21KK0157"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In ovarian cancer (OvCa), achieving complete resection (RO) in initial surgery is crucial for improving prognosis. However, patients with undetected microscopic metastasis post-RO surgery often have poorer outcomes. This study explores prognostic factors for OvCa patients who underwent RO surgery, focusing on the role of ascites cytology as an indicator of microscopic peritoneal metastasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed data from 975 OvCa cases in the Tokai Ovarian Tumor Study Group database (1986\u20132019). Excluding patients without chemotherapy or with distant metastasis, we examined prognostic factors using Cox regression analysis. Propensity score (PS) methods balanced the cytology-positive and -negative groups, with subgroup analysis for clinical stage and ascites volume.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Multivariate analysis identified FIGO stage III and positive ascites cytology as poor prognostic factors for overall and progression-free survival. After PS adjustment, positive ascites cytology also shortened progression-free intervals post-recurrence, especially in cases with peritoneal or lymph node metastasis. Subgroup analysis revealed a more substantial prognostic impact of positive ascites cytology in early-stage cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The present results suggest that in OvCa patients with the R0 status, the presence of tumor cells in ascites is an independent negative prognostic factor and may be an indicator of peritoneal micro-metastasis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyaf046","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:01:38Z","timestamp":1742515298000},"page":"743-750","source":"Crossref","is-referenced-by-count":1,"title":["Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery: a multi-institutional retrospective cohort study"],"prefix":"10.1093","volume":"55","author":[{"given":"Shohei","family":"Iyoshi","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]},{"name":"Institute for Advanced Research, Nagoya University , Furo-cho, Chikusa-ku, Nagoya 464-8601 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Sunohara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tosei General Hospital , 160 Nishioiwake-cho, Seto 489-8642 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5811-3137","authenticated-orcid":false,"given":"Masato","family":"Yoshihara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kunishima","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiri","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]},{"name":"Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, University of Adelaide , Adelaide, SA 5000 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Kitami","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]},{"name":"Department of Gynecologic Oncology, Aichi Cancer Center , 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8601 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Mogi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7762-5039","authenticated-orcid":false,"given":"Kaname","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]},{"name":"Division of Oncology, Department of Clinical Sciences, Lund University , Lund 221 84 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tamauchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Niimi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-9421","authenticated-orcid":false,"given":"Nobuhisa","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Emoto","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-1825","authenticated-orcid":false,"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"2025070702415843500_ref1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2025070702415843500_ref2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br J Cancer"},{"key":"2025070702415843500_ref3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.6004\/jnccn.2008.0060","article-title":"The role of cytoreductive\/debulking surgery in ovarian cancer","volume":"6","author":"Wakabayashi","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"2025070702415843500_ref4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"2025070702415843500_ref5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ygyno.2012.02.024","article-title":"Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining \u201coptimal\u201d residual disease","volume":"125","author":"Chang","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2025070702415843500_ref6","doi-asserted-by":"publisher","first-page":"326.e1","DOI":"10.1016\/j.ajog.2019.05.006","article-title":"A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome","volume":"221","author":"Manning-Geist","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2025070702415843500_ref7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12967-020-02295-y","article-title":"Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival","volume":"18","author":"For the Groupe de Recherche FRANCOGYN","year":"2020","journal-title":"J Transl Med"},{"key":"2025070702415843500_ref8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux pour les etudes des cancers de l\u2019Ovaire (GINECO)","volume":"115","author":"Bois","year":"2009","journal-title":"Cancer"},{"key":"2025070702415843500_ref9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/aogs.13453","article-title":"Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery","volume":"98","author":"S\u00f8rensen","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2025070702415843500_ref10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1136\/ijgc-2020-001505","article-title":"Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer","volume":"31","author":"Greer","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"2025070702415843500_ref11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12905-024-02977-5","article-title":"The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis","volume":"24","author":"Chase","year":"2024","journal-title":"BMC Womens Health"},{"key":"2025070702415843500_ref12","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of clinical oncology clinical practice guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J Clin Oncol"},{"key":"2025070702415843500_ref13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","journal-title":"N Engl J Med"},{"key":"2025070702415843500_ref14","doi-asserted-by":"publisher","first-page":"E933","DOI":"10.1073\/pnas.1319493111","article-title":"Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates","volume":"111","author":"Spring","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025070702415843500_ref15","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/oby.23497","article-title":"Obesity contributes to the stealth peritoneal dissemination of ovarian cancer: a multi-institutional retrospective cohort study","volume":"30","author":"Iyoshi","year":"2022","journal-title":"Obesity"},{"key":"2025070702415843500_ref16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00404-014-3364-8","article-title":"The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer","volume":"290","author":"Zeppernick","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"2025070702415843500_ref17","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/cncr.23390","article-title":"Prognostic factors for high-risk early-stage epithelial ovarian cancer: a gynecologic oncology group study","volume":"112","author":"Chan","year":"2008","journal-title":"Cancer"},{"key":"2025070702415843500_ref18","doi-asserted-by":"publisher","first-page":"15154","DOI":"10.1038\/s41598-021-93718-3","article-title":"A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer","volume":"11","author":"Yoshihara","year":"2021","journal-title":"Sci Rep"},{"key":"2025070702415843500_ref19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10147-016-0985-x","article-title":"Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer","volume":"21","author":"Komiyama","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"2025070702415843500_ref20","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/annonc\/mdn059","article-title":"Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?","volume":"19","author":"Suzuki","year":"2008","journal-title":"Ann Oncol"},{"key":"2025070702415843500_ref21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"2025070702415843500_ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084383","article-title":"Metastatic voyage of ovarian cancer cells in ascites with the assistance of various cellular components","volume":"23","author":"Uno","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/7\/743\/62491195\/hyaf046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/7\/743\/62491195\/hyaf046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T06:42:03Z","timestamp":1751870523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/55\/7\/743\/8088011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,20]]},"published-print":{"date-parts":[[2025,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf046","relation":{},"ISSN":["1465-3621"],"issn-type":[{"type":"electronic","value":"1465-3621"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,20]]}}}